Clinical data proves that Patient Self Testing (PST) greatly improves the amount of time patients are in their optimal therapeutic range (TTR) while significantly decreasing the likelihood of an adverse event during anticoagulation therapy.

View the DataRequest Information


There are multiple studies that examine the benefits of Patient Self Testing. The studies examine the amount of time that patients stay in their therapeutic range. PHM has compiled and summarized multiple studies for your review.

 

If you have any questions about the data or would like to learn more about the benefits of patient self test (PST), please call the PHM support team at (877) 811-9690.

Footnotes:
*Decision Memo for Prothrombin Time (INR) Monitor for Home Anticoagulation Management (CAG-00087N). 2001.
**Bussey HI, Bussey M, Bussey-Smith KL, et al. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study. Pharmacotherapy 2013;33:1136-46.

White Papers

Long-term Self-management of Anticoagulation Therapy

(after mechanical heart valve replacement in outside trial conditions)

Download the PDF

Self-monitoring of Oral Anticoagulation

A systematic review and meta-analysis

Download the PDF